Tryp Therapeutics Valuation
TRYPFDelisted Stock | USD 0.05 0 6.89% |
Tryp Therapeutics seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Tryp Therapeutics from inspecting the company fundamentals such as Return On Equity of -9.22, shares outstanding of 96.42 M, and Shares Owned By Institutions of 0.04 % as well as reviewing its technical indicators and probability of bankruptcy. . In general, most investors recommend locking in undervalued stocks and disposing overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other.
Overvalued
Today
Please note that Tryp Therapeutics' price fluctuation is very steady at this time. Calculation of the real value of Tryp Therapeutics is based on 3 months time horizon. Increasing Tryp Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Tryp otc stock is determined by what a typical buyer is willing to pay for full or partial control of Tryp Therapeutics. Since Tryp Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Tryp OTC Stock. However, Tryp Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 0.05 | Real 0.0465 | Hype 0.05 | Naive 0.0529 |
The real value of Tryp OTC Stock, also known as its intrinsic value, is the underlying worth of Tryp Therapeutics OTC Stock, which is reflected in its stock price. It is based on Tryp Therapeutics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Tryp Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Tryp Therapeutics helps investors to forecast how Tryp otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Tryp Therapeutics more accurately as focusing exclusively on Tryp Therapeutics' fundamentals will not take into account other important factors: Tryp Therapeutics Total Value Analysis
Tryp Therapeutics is at this time projected to have takeover price of 4.17 M with market capitalization of 6.56 M, debt of , and cash on hands of 2.85 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Tryp Therapeutics fundamentals before making investing decisions based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
4.17 M | 6.56 M | 2.85 M |
Tryp Therapeutics Asset Utilization
One of the ways to look at asset utilization of Tryp is to check how much profit was generated for every dollar of assets it reports. Tryp Therapeutics has a negative utilization of assets of -2.05 %, losing $0.0205 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Tryp Therapeutics shows how discouraging it operates for each dollar spent on its assets.Tryp Therapeutics Ownership Allocation
Tryp Therapeutics shows a total of 96.42 Million outstanding shares. Tryp Therapeutics maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Tryp Therapeutics Profitability Analysis
Net Loss for the year was (7.49 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Tryp Therapeutics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Tryp Therapeutics and how it compares across the competition.
About Tryp Therapeutics Valuation
The otc valuation mechanism determines Tryp Therapeutics' current worth on a weekly basis. Our valuation model uses a comparative analysis of Tryp Therapeutics. We calculate exposure to Tryp Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Tryp Therapeutics's related companies.Tryp Therapeutics Inc., a pharmaceutical company, focuses on identifying and developing compounds for diseases with high unmet medical needs. The company was incorporated in 2019 and is based in Kelowna, Canada. Tryp Thrapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Tryp Therapeutics' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Tryp Therapeutics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Tryp Therapeutics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Tryp Therapeutics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Tryp Therapeutics' revenue streams: Identify Tryp Therapeutics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Tryp Therapeutics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Tryp Therapeutics' growth potential: Evaluate Tryp Therapeutics' management, business model, and growth potential.
- Determine Tryp Therapeutics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Tryp Therapeutics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Tryp Therapeutics Growth Indicators
Investing in growth stocks can be very risky. If the company such as Tryp Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding | 96.4 M | |
Retained Earnings | -16.2 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Tryp OTC Stock
If you are still planning to invest in Tryp Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tryp Therapeutics' history and understand the potential risks before investing.
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Bonds Directory Find actively traded corporate debentures issued by US companies |